Table of Contents
ISRN Genetics
Volume 2013, Article ID 204560, 10 pages
http://dx.doi.org/10.5402/2013/204560
Research Article

Analysis of CYP2D6 Allele Frequencies and Identification of Novel SNPs and Sequence Variations in Sardinians

1PharmaNess S.c.a r.l., Parco Scientifico e Tecnologico della Sardegna, Ed. 5, Loc. Piscinamanna, 09010 Pula, Italy
2Unità Operativa di Cagliari, Istituto di Farmacologia Traslazionale del Consiglio Nazionale delle Ricerche CNR-IFT, Parco Scientifico e Tecnologico della Sardegna, Ed. 5, Loc. Piscinamanna, 09010 Pula, Italy
3Dipartimento di Scienze della Vita e dell’Ambiente, Università degli Studi di Cagliari, Laboratori di Genetica, Via T. Fiorelli 1, 09126 Cagliari, Italy

Received 5 July 2012; Accepted 22 August 2012

Academic Editors: M. A. Chiurillo, G. Giovambattista, and K. Omi

Copyright © 2013 Matteo Falzoi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Eichelbaum, M. Ingelman-Sundberg, and W. E. Evans, “Pharmacogenomics and individualized drug therapy,” Annual Review of Medicine, vol. 57, pp. 119–137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Ingelman-Sundberg, “Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity,” Pharmacogenomics Journal, vol. 5, no. 1, pp. 6–13, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. Flockhart, Drug Interactions: Cytochrome P450 Drug Interaction Table, Indiana University School of Medicine, 2008.
  4. B. Bondy and I. Spellmann, “Pharmacogenetics of antipsychotics: useful for the clinician?” Current Opinion in Psychiatry, vol. 20, no. 2, pp. 126–130, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. Human Cytochrome P450 Allele Nomenclature Committee, http://www.cypalleles.ki.se/.
  6. M. Ingelman-Sundberg, S. C. Sim, A. Gomez, and C. Rodriguez-Antona, “Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects,” Pharmacology and Therapeutics, vol. 116, no. 3, pp. 496–526, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Ingelman-Sundberg, “Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future,” Trends in Pharmacological Sciences, vol. 25, no. 4, pp. 193–200, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Falzoi, A. Mossa, E. Congeddu, L. Saba, and L. Pani, “Multiplex genotyping of CYP3A4, CYP3A5, CYP2C9 and CYP2C19 SNPs using MALDI-TOF mass spectrometry,” Pharmacogenomics, vol. 11, no. 4, pp. 559–571, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Lampis, L. Morelli, S. De Virgiliis, M. Congia, and F. Cucca, “The distribution of HLA class II haplotypes reveals that the Sardinian population is genetically differentiated from the other Caucasian populations,” Tissue Antigens, vol. 56, no. 6, pp. 515–521, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. I. A. Eaves, T. R. Merriman, R. A. Barber et al., “The genetically isolated populations of Finland and Sardinia may not be a panacea for linkage disequilibrium mapping of common disease genes,” Nature Genetics, vol. 25, no. 3, pp. 320–323, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Sistonen, A. Sajantila, O. Lao, J. Corander, G. Barbujani, and S. Fuselli, “CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure,” Pharmacogenetics and Genomics, vol. 17, no. 2, pp. 93–101, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Fuselli, I. Dupanloup, E. Frigato et al., “Molecular diversity at the CYP2D6 locus in the Mediterranean region,” European Journal of Human Genetics, vol. 12, no. 11, pp. 916–924, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. Homo sapiens cytochrome P4502D6 (CYP2D6) gene, CYP2D6*1 allele, complete cds, http://www.ncbi.nlm.nih.gov/nucleotide/45024927?
  14. I. Johansson, E. Lundqvist, M. L. Dahl, and M. Ingelman-Sundberg, “PCR-based genotyping for duplicated and deleted CYP2D6 genes,” Pharmacogenetics, vol. 6, no. 4, pp. 351–355, 1996. View at Google Scholar · View at Scopus
  15. QIAGEN LongRange PCR Handbook 2008 http://www.qiagen.com/default.aspx.
  16. SEQUENOM RealSNPTM Assay Database, https://seqpws1.sequenom.com/AssayDesignerSuite.html#design:new=Genotyping.
  17. Primer3 v. 0.4.0, http://frodo.wi.mit.edu/primer3/.
  18. C. Sachse, J. Brockmöller, S. Bauer, and I. Roots, “Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences,” American Journal of Human Genetics, vol. 60, no. 2, pp. 284–295, 1997. View at Google Scholar · View at Scopus
  19. Human cytochrome P450 IID6 (CYP2D6) gene, complete cds, http://www.ncbi.nlm.nih.gov/nuccore/181303?
  20. TaqMan Copy Number Assays Protocol, 2009, http://www.appliedbiosystems.com/.
  21. M. Stephens, N. J. Smith, and P. Donnelly, “A new statistical method for haplotype reconstruction from population data,” American Journal of Human Genetics, vol. 68, no. 4, pp. 978–989, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Excoffier and M. Slatkin, “Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population,” Molecular Biology and Evolution, vol. 12, no. 5, pp. 921–927, 1995. View at Google Scholar · View at Scopus
  23. S. Raimundo, C. Toscano, K. Klein et al., “A novel intronic mutation, 2988G>A, with high predictivity for impaired function of cytochrome P450 2D6 in white subjects,” Clinical Pharmacology and Therapeutics, vol. 76, no. 2, pp. 128–138, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. L. D. Bradford, “CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants,” Pharmacogenomics, vol. 3, no. 2, pp. 229–243, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Marez, M. Legrand, N. Sabbagh et al., “Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution,” Pharmacogenetics, vol. 7, no. 3, pp. 193–202, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Ingelman-Sundberg, “Implications of polymorphic cytochrome P450-dependent drug metabolism for drug development,” Drug Metabolism and Disposition, vol. 29, no. 4, pp. 570–573, 2001. View at Google Scholar · View at Scopus
  27. A. Gaedigk, A. Bhathena, L. Ndjountché et al., “Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans,” Pharmacogenomics Journal, vol. 5, no. 3, pp. 173–182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Gaedigk, L. Ndjountché, J. S. Leeder et al., “Limited association of the 2988G>A single nucleotide polymorphism with CYP2D6*41 in black subjects,” Clinical Pharmacology and Therapeutics, vol. 77, no. 3, pp. 228–231, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Shimada, F. Tsumura, H. Yamazaki, F. P. Guengerich, and K. Inoue, “Characterization of (±)-bufuralol hydroxylation activities in liver microsomes of Japanese and Caucasian subjects genotyped for CYP2D6,” Pharmacogenetics, vol. 11, no. 2, pp. 143–156, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. ss469415642 (2011) CYP2D6 3176C>T, http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ss.cgi?ss=469415642.
  31. ss469415643 (2011) CYP2D6 3948T>G, http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ss.cgi?ss=469415643.
  32. ss470263991 (2011) CYP2D6 -948C>A, http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ss.cgi?ss=470263991.
  33. M. Falzoi, L. Pira, P. Lazzari, and L. Pani. GenBank, Homo sapiens haplotype 1 cytochrome P450 2D6 variant (CYP2D6) gene, CYP2D6*2M allele, complete cds, JN716373. 1, 2011, http://www.ncbi.nlm.nih.gov/nuccore/JN716373.
  34. M. Falzoi, L. Pira, P. Lazzari, and L. Pani, Homo sapiens haplotype 2 cytochrome P450 2D6 variant (CYP2D6) gene, CYP2D6*2M allele, complete cds. GenBank: JN716374. 1, 2011, http://www.ncbi.nlm.nih.gov/nuccore/JN716374.
  35. M. Falzoi, L. Pira, P. Lazzari, and L. Pani, Homo sapiens haplotype 3 cytochrome P450 2D6 variant (CYP2D6) gene, CYP2D6*M/CYP2D6*41 hybrid allele, complete cds. GenBank: JN716375. 1, 2011, http://www.ncbi.nlm.nih.gov/nuccore/JN716375.
  36. M. Falzoi, L. Pira, P. Lazzari, and L. Pani, Homo sapiens haplotype 4 cytochrome P450 2D6 variant (CYP2D6) gene, CYP2D6*2M/CYP2D6*41 hybrid allele, complete cds. GenBank: JN716376. 1, 2011, http://www.ncbi.nlm.nih.gov/nuccore/JN716376.